4882 — Perseus Proteomics Balance Sheet
0.000.00%
- ¥6bn
- ¥4bn
- ¥120m
Annual balance sheet for Perseus Proteomics, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | Yuho | Yuho | Yuho | Tanshin |
Standards: | JAS | JAS | JAS | JAS | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 1,069 | 3,215 | 2,445 | 1,541 | 1,668 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 30.7 | 45.4 | 51.4 | 83.8 | 72.5 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,109 | 3,291 | 2,515 | 1,651 | 1,776 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0 | 0 | 0 | 0 | 0 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 1,119 | 3,301 | 2,567 | 1,694 | 1,819 |
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 34.9 | 148 | 111 | 129 | 125 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 34.9 | 148 | 170 | 295 | 386 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 1,084 | 3,152 | 2,397 | 1,398 | 1,432 |
Total Liabilities & Shareholders' Equity | 1,119 | 3,301 | 2,567 | 1,694 | 1,819 |
Total Common Shares Outstanding |